Journal Article Summary

The article investigates the role of angiotensin-converting enzyme 2 (ACE2) in the development of atherosclerosis, a condition characterized by the buildup of fatty deposits in arteries. Understanding this relationship is important because atherosclerosis can lead to serious cardiovascular diseases, including heart attacks and strokes. ACE2 is known to convert angiotensin II, a molecule that can constrict blood vessels and promote inflammation, into angiotensin-(1–7), which has protective effects. By studying ACE2's function, researchers aim to uncover potential therapeutic targets for preventing or treating atherosclerosis.

In the study, researchers used genetically modified mice that lacked ACE2 and were also deficient in LDL receptors, which are crucial for cholesterol regulation. These mice were fed a high-fat diet for three months to induce atherosclerosis. The findings revealed that the absence of ACE2 led to an increase in atherosclerotic lesions in these mice, indicating that ACE2 plays a protective role against the development of atherosclerosis. Additionally, the study found that ACE2 deficiency in bone marrow-derived cells also contributed to increased atherosclerosis, suggesting that ACE2's effects are not limited to systemic circulation but also involve local immune cells.

The study has some limitations, including its reliance on animal models, which may not fully replicate human disease processes. Additionally, while the research highlights the importance of ACE2 in regulating atherosclerosis, it does not establish direct clinical implications for patients. Readers should discuss with their healthcare providers the significance of these findings, especially if they have risk factors for cardiovascular disease. Understanding the role of ACE2 may lead to new strategies for managing atherosclerosis and improving heart health.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Thatcher Sean E., Zhang Xuan, Howatt Deborah A., Lu Hong, Gurley Susan B., Daugherty Alan, Cassis Lisa A.. ACE2 Deficiency in Whole Body or Bone Marrow-Derived Cells Increases Atherosclerosis in LDL Receptor −/− Mice. Arteriosclerosis, thrombosis, and vascular biology 2011. DOI: 10.1161/ATVBAHA.110.221614. PMID: 21252069. PMCID: PMC3086633.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]